Avicanna’s CBG Products Reach 19 Countries: Denmark Joins Global Expansion

Avicanna Inc. (OTC: AVCNF) biopharmaceutical company announced Thursday the successful export of its Aureus-branded cannabigerol (CBG) products to Denmark.

This marks the 19th international market for Aureus-branded products and the 22nd market overall for Avicanna’s product range. The export was facilitated through Avicanna’s majority-owned subsidiary, Santa Marta Golden Hemp SAS.

What Is CBG?

Cannabigerol (CBG) is a non-psychoactive cannabinoid found in the cannabis plant. Often referred to as the “mother cannabinoid,” CBG is the precursor to other cannabinoids like THC and CBD. Specialized extraction methods can isolate CBG for its distinct properties.

CBG has been researched for potential therapeutic effects, including anti-inflammatory, antibacterial and neuroprotective benefits. It is also thought to …

Full story available on Benzinga.com